As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
HOME > LATEST
LATEST
-
ORGANIZATION Indicators Needed to Frame Pharma as Growth Market in Japan, Says JPMA Policy Chief
August 29, 2025
-
BUSINESS New PIII Breast Cancer Trial Kicks Off for Daiichi’s HER3 ADC
August 29, 2025
-
BUSINESS Sanofi Files for Subcutaneous Formulation of Sarclisa in Japan
August 29, 2025
-
REGULATORY Diagnostics Industry Urges Mechanism to Reflect Rising Costs in Reimbursement
August 29, 2025
-
COLUMN AI in Japanese Pharma: Now, Not Later!
August 29, 2025
-
ORGANIZATION Wage Hikes Average in Low 4% Range, Similar to Last Year: Pharma Labor Group
August 28, 2025
-
BUSINESS BeOne’s Tevimbra Could Stand Apart in PD-1 Class with Unique Feature: Expert
August 28, 2025
-
BUSINESS Sawai to Raise Awareness for Launch of Alcoholism Therapy App HAUDY
August 28, 2025
-
BUSINESS Meiji Breaks Ground on “Dual-Use” Plant for Antibiotics and Vaccines
August 28, 2025
-
REGULATORY Japan to Expand List of “Stable Supply Medicines” to 759 APIs, Adding Vaccines and Blood Products
August 28, 2025
-
BUSINESS Nihon Chouzai Shuts Down FINDAT Formulary Biz amid Tepid Demand
August 28, 2025
-
REGULATORY Japan to Apply Drug Pricing Rules for Krystal Gene Therapy: Chuikyo
August 28, 2025
-
BUSINESS Amicus’ Pompe Disease Drugs Hit Japan Market
August 28, 2025
-
BUSINESS LP.8.1-Tailored Nuvaxovid COVID Jab Approved in Japan: Takeda
August 28, 2025
-
REGULATORY MHLW's FY2026 Budget Bid Prioritizes Innovation, Stockpiles, Ultra-Orphan Support
August 27, 2025
-
COMMENTARY Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
August 27, 2025
-
REGULATORY MHLW Pharma Bureau Seeks FY2026 Budget to Bolster PMDA and Speed Up SaMD Reviews
August 27, 2025
-
ORGANIZATION Victims’ Group Urges Stronger Safety Measures amid New Drug Modalities
August 27, 2025
-
BUSINESS Kringle, Keio Pair Up on HGF Therapy for Peripheral Nerve Injury
August 27, 2025
-
REGULATORY MHLW Seeks New R&D Tax Credit Scheme for Strategic Technologies in FY2026 Proposal
August 27, 2025
ページ
Japan is set to tighten reimbursement rules for regenerative medicine products granted conditional, time-limited approval, with Central Social Insurance Medical…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…